Submit manuscript >>


View a Chinese translation of this page here.

Archives of Disease in Childhood: Fetal & Neonatal is a bimonthly edition of ADC that brings together quality research and reviews in the field of perinatal and neonatal medicine. It focuses on all aspects of child health and disease from the perinatal period (in the Fetal and Neonatal edition) through to adolescence.

Editorial policy

Archives of Disease in Childhood: Fetal & Neonatal adheres to the highest standards concerning its editorial policies on publication ethics, scientific misconduct, consent and peer review criteria. The journal follows guidance produced by bodies that include the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME) and the International Committee of Medical Journal Editors (ICMJE).To view all BMJ Journal policies please refer to the BMJ Author Hub policies page.

We take seriously all possible misconduct. If an Editor, author or reader has concerns that a submitted article describes something that might be considered to constitute misconduct in research, publication or professional behaviour they should forward their concerns to the journal. The publisher will deal with allegations appropriately.

Articles are published under an exclusive licence or non-exclusive licence for UK Crown employees or where BMJ has agreed CC BY applies. For US Federal Government officers or employees acting as part of their official duties, the terms are as stated in accordance with our licence terms. Authors or their employers retain copyright. Open access articles can be reused under the terms of the relevant Creative Commons licence to facilitate reuse of the content; please refer to the Archives of Disease in Childhood: Fetal & Neonatal Author Licence for the applicable Creative Commons licences. More information on copyright and authors’ rights.

As the author you may wish to post your article in a PrePrint service, institutional or subject repository or a scientific social sharing network. For more information on author self archiving and rights to reuse content – which are dependent on the licence you have obtained – please refer to the BMJ author self archiving and permissions policies page.

Peer review process

Articles submitted to Archives of Disease in Childhood: Fetal & Neonatal are subject to peer review. The journal operates single blind peer review whereby the names of the reviewers are hidden from the author. Manuscripts authored by a member of a journal’s editorial team are independently peer reviewed; an editor will have no input or influence on the peer review process or publication decision for their own article. For more information on what to expect during the peer review process please refer to BMJ Author Hub – the peer review process.

BMJ requests that all reviewers adhere to a set of basic principles and standards during the peer-review process in research publication; these are based on the COPE Ethical Guidelines for Peer Reviewers. Please refer to our peer review terms and conditions policy page.

BMJ is committed to transparency. Every article we publish includes a description of its provenance (commissioned or not commissioned) and whether it was internally or externally peer reviewed.

Plagiarism is the appropriation of the language, ideas or thoughts of another without crediting their true source and representation of them as one’s own original work. BMJ is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. BMJ runs manuscripts through iThenticate during the peer review process. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting

Manuscript transfer

BMJ and the Royal College of Paediatrics and Child Health have a facility for transferring manuscripts among their paediatric journals. Authors submitting to the flagship journal Archives of Disease in Childhood can choose BMJ Paediatrics Open as an ‘alternate journal’.

Once authors agree for their manuscript to be transferred to another BMJ journal, all versions of the manuscript, any supplementary files and peer review comments will automatically be transferred on the author’s behalf. Please note that there is no guarantee of acceptance. Contact the editorial team for more information or assistance.

Article publishing charges

During submission, authors can choose to have their article published open access for 1,950 GBP (exclusive of VAT for UK and EU authors). There are no submission, page or colour figure charges.

For more information on open access, funder compliance and institutional programmes please refer to the BMJ Author Hub open access page.

Data sharing

Archives of Disease in Childhood: Fetal & Neonatal adheres to BMJ’s Tier 3 data policy. We strongly encourage that data generated by your research that supports your article be made available as soon as possible, wherever legally and ethically possible. All research articles must contain a Data Availability Statement. For more information and FAQs, please see BMJ’s full Data Sharing Policy page.

Paediatric and Perinatal Drug Therapy

Articles for the Paediatric and Perinatal Drug Therapy section should follow the same submission guidelines as the relevant article type, ie, if you are submitting a full original report for the PPDT section it should adhere to the “Original reports” instructions as outlined below.

Submission guidelines

Please review the below article type specifications including the required article lengths, illustrations, table limits and reference counts. The word count excludes the title page, abstract, tables, acknowledgements, contributions and references. Manuscripts should be as succinct as possible.

For further support when making your submission please refer to the resources available on the BMJ Author Hub. Here you can also find general formatting guidelines across BMJ and a formatting checklist. You may also wish to use the language editing and translation services provided by BMJ Author Services.

If your article is accepted you can take advantage of BMJ’s partnership with Kudos, a free service to help you maximise your article’s reach.

Original reports

These should report original research. (max 2500 words, excluding abstract, tables and figures and references). The body of the report should be double spaced. The tables should be single spaced and the tables and figures should be at the end of the submission after the references. Please note that all RCT must be appropriately registered and this should be noted on the cover page.


The title should have no more than 10 words. If relevant, the title should include information as to whether the paper is a randomised control trial, meta-analysis, audit, observational study, etc.


The abstract of an experimental or observational study must clearly state in sequence and in not more than 250 words (i) the main purpose of the study, (ii) the essential elements of the design of the study, (iii) the most important results illustrated by numerical data but not p values, and (iv) the implications and relevance of the results.

We require a structured abstract of up to 250 words for reports of randomised controlled trials and meta-analyses, and we encourage it for other studies, where appropriate. The following headings should be used for original research:

  • Objective
  • Design
  • Setting
  • Patients
  • Interventions
  • Main outcome measures
  • Results: give numerical data rather than vague statements that drug x produced a better response than drug y. Favour confidence intervals over p values, and give the numerical data on which any p value is based.
  • Conclusions: do not make any claims that are not supported by data in the paper in the abstract.

Important considerations

  • All research reports involving human subjects must contain a statement about ethics committee approval (or equivalent) at the end of the methods section.
  • On a separate page (before the references) all original papers should include:
    • “What is already known on this topic” – followed by a maximum of 3 brief statements (no more than 25 words per statement);
    • “What this study adds” – followed by a maximum of 3 brief statements (no more than 25 words per statement).
  • Illustrations should be used only when data cannot be expressed clearly in any other way. When graphs are submitted the numerical data on which they are based should be uploaded to ScholarOne as a supplementary file.
  • It is a journal requirement that the EQUATOR checklist relevant to the study is supplied. Research checklists should be uploaded during the submission process; if these are not applicable to your research please state the reason in your cover letter.

    Further details of RCTs and systematic reviews.

    Word count: up to 2500 words (excluding title page, abstract, tables, figures, and references)
    Structured abstract: up to 250 words
    Tables/Illustrations: up to 5
    References: up to 40
    Additional material may be considered as data supplements.

Short reports / Case reports

Short reports are brief reports of original research and case reports are any report/case history of four cases or less. ADC only rarely publishes case reports/series and to be successful, the paper must have either exceptional hypothesis generating strength or a powerful and novel clinical message. The abstract of a paper that focuses on a case report(s) must summarise the essential descriptive elements of the case(s) and indicate their relevance and importance. If more illustrations are required, the text must be reduced accordingly. The title should be no longer than seven words. All case reports must be submitted with a scanned patient consent form uploaded as a supplemental file. Please click here for the Patient Consent Form.

Word count: up to 1200 words (excluding title page, abstract, tables, figures, and references)
Abstract: up to 150 words
Tables/Illustrations: up to 2 small tables or images
References: up to 5

Letters to the editor

The editor encourages submissions of important and topical observations or original exploratory research as a letter to the editor.

Word count: up to 500 words
Abstract: not required
Tables/Illustrations: up to 2
References: up to 4


To register a question, and to submit completed Archimedes topics, please email first. The creation of such a topic summary follows this process:

  • Selection of a clinical scenario
  • Definition of the clinical question
  • Search for answers
  • Appraise the evidence
  • Create a critically appraised topic (CAT)
  • Summarise as a best evidence topic (BET)

The best evidence topic is the final accumulation of the critical appraisal. The strict format allows the casual reader to extract important information quickly and easily. An example template is available here.

Images in Neonatal Medicine

This is a really useful format for trainees, and those who are keen to start publishing, as well as established authors. We would welcome submissions to the above categories should take the form of a striking or clinically important image, as well as up to 250 words of text (and up to 5 references). The text should carry a brief clinical outline, and a clear clinical message or learning point. Two images can be submitted simultaneously, but this will require reducing the word count.

One tip is perhaps to compare the clinical image with Google Images, to ensure that the image is not replicating a well-known appearance. Please ensure that for all Image submissions, you also upload a scanned patient consent form as a supplemental file. Please click here for the Patient Consent Form. If an image is good but describing a well-known appearance: consider the criteria for submitting an Epilogue instead.

Rapid responses to articles published

Letters in response to articles published in the Archives of Disease in Childhood are welcome and should be submitted electronically via the journal’s website and NOT to Scholar One. Contributors should go to the abstract or full text of the article in question. At the top right corner of each article is a “contents box”. Click on the “eLetters: Submit a response to this article” link.

Letters relating to or responding to previously published items in the journal will be shown to those authors, where appropriate.

Word count: up to 300 words
Abstract: not required
Tables/Illustrations: up to 2 (but must be essential)
References: up to 5


These are commentaries commissioned by the editors to provide background and context for published articles.

Word count: up to 1200 words
Abstract: not required
Tables/Illustrations: up to 2
References: up to 5

Leading Articles/Reviews

These are generally commissioned. Leading articles and reviews can be discussed with either the Editor in Chief or Commissioning Editor. Editors will make the final decision regarding whether an article is classified as a leading article or review. In general reviews focus on clinical issues, whereas leading articles reflect on issues that are broader in scope than a specific clinical entity. Reviews should be no longer that 2500-3000 words (exclusive of titles, tables, figures, and references), and the word count for leading articles is at the discretion of the editor but generally 1500 – 2500

For Leading Articles the title should have no more than 10 words. No abstract is required.

For Reviews an abstract is required and should be a brief summary of the article.

Word count: 2500 – 3000 (review) and 1500-2500 (leading article)
Figures/tables: are encouraged
References: 30-40 should suffice


The BMJ Publishing Group journals are willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of:

  • The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
  • The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
  • The BMJPG itself may have proposals for supplements where sponsorship may be necessary.
  • A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.

In all cases, it is vital that the journal’s integrity, independence and academic reputation is not compromised in any way.

For further information on criteria that must be fulfilled, download the supplements guidelines.

When contacting us regarding a potential supplement, please include as much of the information below as possible.

  • Journal in which you would like the supplement published
  • Title of supplement and/or meeting on which it is based
  • Date of meeting on which it is based
  • Proposed table of contents with provisional article titles and proposed authors
  • An indication of whether authors have agreed to participate
  • Sponsor information including any relevant deadlines
  • An indication of the expected length of each paper Guest Editor proposals if appropriate